Toll-like receptor 4 gene polymorphism and giant cell arteritis susceptibility: A cumulative meta-analysis

Autoimmunity Reviews

Volumn 10, Issue 12, 2011, Pages 790-792

  Alvarez Rodriguez, Lorena ^a   Muñoz Cacho, Pedro ^c   Lopez Hoyos, Marcos ^a   Beares, Ignacio ^a   Mata, Cristina ^b   Calvo Alen, Jaime ^b   Villa, Ignacio ^b   Martinez Taboada, Victor Manuel ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b Section of Rheumatology   (Spain)

^c Servicio Cantabro de Salud   (Spain)

Author keywords

Gene polymorphism; Giant cell arteritis; Meta analysis; Toll like receptor 4

Indexed keywords

TOLL LIKE RECEPTOR 4;

CASE CONTROL STUDY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GEOGRAPHIC DISTRIBUTION; GIANT CELL ARTERITIS; HUMAN; MEDICAL LITERATURE; PUBLICATION; RECEPTOR GENE; REVIEW; SYSTEMATIC REVIEW;

CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GIANT CELL ARTERITIS; HUMANS; POLYMORPHISM, GENETIC; TOLL-LIKE RECEPTOR 4;

EID: 80053253983     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2011.06.002     Document Type: Review

References (25)

1. Huston K.A., Hunder G.G., Lie J.T., Kennedy K.H., Elveback L.R. Temporal arteritis. A 25year epidemiological, clinical and pathologic study. Ann Intern Med 1978, 88:162-167.
2. Martinez-Taboada V.M., Goronzy J.J., Weyand C.M. Conceptos actuales sobre la patogenia de la arteritis de células gigantes. Rev Esp Reumatol 1994, 21:293-299.
3. Martínez-Taboda V.M., Bartolome M.J., Lopez-Hoyos M., Blanco R., Mata C., Calvo J., et al. HLA-DRB1 allele distribution in polymyalgia rheumatica and giant cell arteritis: influence on clinical subgroups and prognosis. Semin Arthritis Rheum 2004, 34:454-464.
4. Pacheco M.J., Amado J.A., Lopez-Hoyos M., Blanco R., Garcia-Unzueta M.T., Rodriguez-Valverde V., et al. Hypothalamic-pituitary-adrenocortical axis function in patients with polymyalgia rheumatica and giant cell arteritis. Semin Arthritis Rheum 2003, 32:266-272.
5. Martinez-Taboada V.M., Bartolome M.J., Fernandez-Gonzalez M.D., Blanco R., Rodriguez-Valverde V., Lopez-Hoyos M. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy. Rheumatology (Oxford) 2003, 42:1055-1061.
6. Lopez-Hoyos M., Bartolome-Pacheco M.J., Blanco R., Rodriguez-Valverde V., Martinez-Taboada V.M. Selective T cell receptor decrease in peripheral blood T lymphocytes of patients with polymyalgia rheumatica and giant cell arteritis. Ann Rheum Dis 2004, 63:54-60.
7. Martinez-Taboada V., Hunder N.N.H., Hunder G.G., Weyand C.M., Goronzy J.J. Recognition of tissue residing antigen by T cells in vasculitic lesions of giant cell arteritis. J Mol Med 1996, 74:695-703.
8. Brack A., Geisler A., Martínez-Taboada V., Younge B.R., Goronzy J.J., Weyand C.M. Giant cell vasculitis is a T cell-dependent disease. Mol Med 1997, 8:530-543.
9. González-Gay M.A., Amoli M.M., Garcia-Porrua C., Ollier W.E. Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica. Semin Arthritis Rheum 2003, 33:38-48.
10. Martínez-Taboada V.M., Alvarez Rodriguez L., Ruiz Soto M., Marín M.J., Lopez-Hoyos M. Giant cell arteritis and polymyalgia rheumatica: role of cytokines in the pathogenesis and implications for treatment. Cytokine 2008, 44:207-220.
11. Alvarez-Rodriguez L., Lopez-Hoyos M., Beares I., Muñoz-Cacho P., Mata C., Calvo-Alen J., et al. Lack of association between toll-like receptor 4 gene polymorphisms and giant cell arteritis. Rheumatology (Oxford) May 17 2011, [Epub ahead of print].
12. Palomino-Morales R., Torres O., Vazquez-Rodriguez T.R., Morado I.C., Castañeda S., Callejas-Rubio J.L., et al. Association between toll-like receptor 4 gene polymorphism and biopsy-proven giant cell arteritis. J Rheumatol 2009, 36:1501-1506.
13. Boiardi L., Casali B., Farnetti E., Pipitone N., Nicoli D., Macchioni P., et al. Toll-like receptor 4 (TLR4) gene polymorphisms in giant cell arteritis. Clin Exp Rheumatol 2009, 27(Suppl. 52):S40-S44.
14. Borenstein M., Hedges L.V., Higgins J.P.T., Rothstein H.R. Publication bias. Introduction to meta-analysis 2009, 277-292. Wiley & Sons, Chichester. M. Borenstein, L.V. Hedges, J.P.T. Higgins, H.R. Rothstein (Eds.).
15. Egger M., Davey Smith G., Schneider M. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
16. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analysis. BMJ 2003, 327:557-560.
17. Lau J., Schmid C.H., Chalmers T.C. Cumulative meta-analysis of clinical trials builds evidence for exemplary medical care. J Clin Epidemiol 1995, 48:45-57.
18. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
19. Borenstein M., Hedges L.V., Higgins J.P.T., Rothstein H.R. Introduction to meta-analysis 2009, John Wiley & Sons, Ltd., Chichester, UK.
20. Bagos P.G., Nikolopoulos G.K. Generalized least squares for assessing trends in cumulative meta-analysis with applications in genetic epidemiology. J Clin Epidemiol 2009 Oct, 62(10):1037-1044. [Epub 2009 Apr 5].
21. Zintzaras E., Lau J. Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol 2008 Jul, 61(7):634-645.
22. Sterne J., Becker B., Egger M. The funnel plot. Publication bias in meta-analysis. prevention, assessment and adjustments 2005, Wiley, Chichester. H. Rothstein, A. Sutton, M. Borenstein (Eds.).
23. Ioannidis J.P., Ntzani E.E., Trikalinos T.A., Contopoulos-Ioannidis D.G. Replication validity of genetic association studies. Nat Genet 2001, 29:306-309.
24. Kraft P. Curses-winner's and otherwise-in genetic epidemiology. Epidemiology 2008, 19:649-651.
25. Zollner S., Pritchard J.K. Overcoming the winner's curse: estimating penetrance parameters from case-control data. Am J Hum Genet 2007, 80:605-615.